Latest MGTA reports update at 2024-05-09: 2024-Q1 ∙ 2023-Q4 ∙ 2023-Q1

Magenta Therapeutics MGTA

$ 0.7 -7.74%

Magenta Therapeutics Financial Statements 2011-2024 | MGTA

Annual Financial Statements Magenta Therapeutics

	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
Market Cap	3.61 M	664 K	173 M	427 M	455 M	126 M	-	-	-	-	-	-	-
Shares	5.15 M	874 K	54.9 M	48.4 M	37 M	18.4 M	-	-	-	-	-	-	-
Historical Prices	0.7	0.76	3.15	10.5	11.8	13.1	-	-	-	-	-	-	-
Net Income	-43.6 M	-28.5 M	-71.1 M	-74.9 M	-76.8 M	-57.5 M	-35.5 M	-9.43 M	-	-	-	-	-
Revenue	-	-	-	-	-	-	-	-	-	-	-	-	-
Cost of Revenue	-	-	-	-	-	-	-	-	-	-	-	-	-
Gross Profit	-	-	-	-	-	-	-	-	-	-	-	-	-
Operating Income	-48.2 M	-29.7 M	-74.7 M	-78.7 M	-83 M	-60 M	-35.7 M	-9.27 M	-	-	-	-	-
Interest Expense	-60 K	-52 K	-	-	-	-	-	163 K	-	-	-	-	-
EBITDA	-48.1 M	-29.7 M	-72.7 M	-76.7 M	-81.1 M	-59.1 M	-35.1 M	-9.26 M	-	-	-	-	-
Operating Expenses	51 M	36.1 M	74.7 M	78.7 M	83 M	60 M	-	-	-	-	-	-	-
General and Administrative Expenses	18.2 M	6.74 M	27.9 M	28.1 M	23.8 M	18.6 M	7.83 M	3.49 M	-	-	-	-	-

All numbers in USD currency

Quarterly Income Statement Magenta Therapeutics

	2024-Q1	2023-Q4	2023-Q3	2023-Q2	2023-Q1	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
Shares	25.7 M	14.8 M	3.91 M	60.7 M	875 K	875 K	874 K	58.8 M	58.8 M	58.8 M	58.6 M	53.7 M	48.6 M	48.5 M	48.3 M	39.6 M	39.4 M	39.3 M	38.8 M	36.7 M	33.4 M	33.3 M	33 M	4.39 M	2.47 M	2.35 M	2.01 M	1.73 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Net Income	-13.7 M	-	-14.8 M	-3.28 M	-7.09 M	-	-7.78 M	-17.3 M	-23 M	-	-17.4 M	-16.9 M	-17.5 M	-	-74.9 M	-74.9 M	-74.9 M	-23.2 M	-76.8 M	-76.8 M	-76.8 M	-16.7 M	-57.5 M	-57.5 M	-57.5 M	-8.04 M	35.5 M	35.5 M	-4.81 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Revenue	-	-	924 K	-	-	-	1.17 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Cost of Revenue	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Gross Profit	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Operating Income	-17.8 M	-	-15.8 M	-7.38 M	-7.68 M	-	-8.25 M	-18.1 M	-23.8 M	-	-18.2 M	-17.6 M	-18.7 M	-	-18.4 M	-20 M	-21.2 M	-24.6 M	-22.6 M	-19.3 M	-16.4 M	-17.9 M	-16.7 M	-14 M	-11.3 M	-8.17 M	-7.02 M	-15.7 M	-4.81 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Interest Expense	-114 K	-	-15 K	-	-3 K	-	-2 K	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
EBITDA	-17.8 M	-	-15.7 M	-	-7.67 M	-	-8.25 M	-18.1 M	-23.3 M	-	-16.8 M	-17.6 M	-18.2 M	-	-16.9 M	-19 M	-20.8 M	-24.6 M	-21.3 M	-18.5 M	-15.9 M	-17.9 M	-16.2 M	-13.7 M	-11.2 M	-8.17 M	-6.77 M	-15.6 M	-4.81 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Operating Expenses	18.7 M	-	16.7 M	7.38 M	8.16 M	-	9.43 M	18.1 M	23.8 M	-	18.2 M	17.6 M	18.7 M	-	18.4 M	20 M	21.2 M	-	22.6 M	19.3 M	16.4 M	-	16.7 M	14 M	11.3 M	-	7.02 M	15.7 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
General and Administrative Expenses	5.64 M	-	8.72 M	5.32 M	2.31 M	-	2.21 M	6.48 M	7.29 M	-	7.45 M	6.48 M	6.97 M	-	6.6 M	7.4 M	7.28 M	-	6.12 M	5.9 M	5.81 M	-	5.28 M	4.34 M	3.46 M	-	1.8 M	1.92 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

All numbers in USD currency